RT Journal Article
SR Electronic
T1 [<sup>18</sup>F]FDG-PET Evaluation of Spinal Pathology in Patients in Oncology: Pearls and Pitfalls for the Neuroradiologist
JF American Journal of Neuroradiology
JO Am. J. Neuroradiol.
FD American Society of Neuroradiology
SP 332
OP 340
DO 10.3174/ajnr.A7308
VO 43
IS 3
A1 Patel, P.Y.
A1 Dalal, I.
A1 Griffith, B.
YR 2022
UL http://www.ajnr.org/content/43/3/332.abstract
AB SUMMARY: [18F]FDG-PET is a widely used technique for specific evaluation of disease and treatment response in oncology. However, the principles behind [18F]FDG-PET imaging allow a wide-ranging array of benign and malignant pathologies to be identified on both initial and routine surveillance imaging. This is important for clinicians and radiologists, alike, in that effective and accurate evaluation of malignancy and metastatic disease, specifically involving the spine and central nervous system, is crucial. In this article, we review the normal and posttherapy appearance of the spine on [18F]FDG-PET, the various types and patterns of metastatic disease that involve the spine and spinal cord, and, finally, important spinal pathologies that may mimic malignancy on [18F]FDG-PET.G-CSFgranulocyte colony-stimulating factorsISCMintramedullary spinal cord metastasisSUVstandard uptake valueSUVmaxmaximum standard uptake value